25 XP   0   0   10

Capricor Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Capricor together

PenkeI guess you are interested in Capricor Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Capricor Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Capricor Therapeutics Inc

I send you an email if I find something interesting about Capricor Therapeutics Inc.

Quick analysis of Capricor (30 sec.)










What can you expect buying and holding a share of Capricor? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.72
Expected worth in 1 year
$1.06
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$0.34
Return On Investment
6.2%

For what price can you sell your share?

Current Price per Share
$5.55
Expected price per share
$3.3899 - $7.28
How sure are you?
50%

1. Valuation of Capricor (5 min.)




Live pricePrice per Share (EOD)

$5.55

Intrinsic Value Per Share

$-16.41 - $-0.34

Total Value Per Share

$-15.69 - $0.38

2. Growth of Capricor (5 min.)




Is Capricor growing?

Current yearPrevious yearGrowGrow %
How rich?$22.6m$17.6m-$10.2m-137.2%

How much money is Capricor making?

Current yearPrevious yearGrowGrow %
Making money$98.5m-$7.1m$105.7m107.3%
Net Profit Margin3,346.4%-302.8%--

How much money comes from the company's main activities?

3. Financial Health of Capricor (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#578 / 1019

Most Revenue
#337 / 1019

Most Profit
#31 / 1019

Most Efficient
#12 / 1019

What can you expect buying and holding a share of Capricor? (5 min.)

Welcome investor! Capricor's management wants to use your money to grow the business. In return you get a share of Capricor.

What can you expect buying and holding a share of Capricor?

First you should know what it really means to hold a share of Capricor. And how you can make/lose money.

Speculation

The Price per Share of Capricor is $5.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Capricor.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Capricor, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.72. Based on the TTM, the Book Value Change Per Share is $0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Capricor.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.02-0.4%-0.18-3.2%-0.23-4.1%-0.15-2.6%-0.11-2.0%
Usd Book Value Change Per Share0.7713.9%0.091.5%-0.16-2.8%0.030.5%0.020.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.7713.9%0.091.5%-0.16-2.8%0.030.5%0.020.3%
Usd Price Per Share4.89-4.33-4.20-3.70-3.52-
Price to Earnings Ratio-50.54--16.03--4.67--9.07--9.77-
Price-to-Total Gains Ratio6.32--21.17--31.32--18.52--66.19-
Price to Book Ratio6.82-5.78-8.21-8.79-47.68-
Price-to-Total Gains Ratio6.32--21.17--31.32--18.52--66.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.55
Number of shares180
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.090.03
Usd Total Gains Per Share0.090.03
Gains per Quarter (180 shares)15.455.14
Gains per Year (180 shares)61.8020.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10625202111
2012411404132
3018517606253
4024723808274
50309300010395
603713620123116
704334240144137
804944860164158
905565480185179
1006186100206200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.088.00.01.1%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%18.068.03.020.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.089.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%12.028.00.030.0%18.068.03.020.2%

Fundamentals of Capricor

About Capricor Therapeutics Inc

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-11 03:25:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Capricor Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Capricor earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • A Net Profit Margin of -6.3% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Capricor Therapeutics Inc:

  • The MRQ is -6.3%. The company is making a loss. -1
  • The TTM is 3,346.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM3,346.4%-3,352.7%
TTM3,346.4%YOY-302.8%+3,649.2%
TTM3,346.4%5Y-2,234.2%+5,580.5%
5Y-2,234.2%10Y-1,305.5%-928.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-197.2%+190.9%
TTM3,346.4%-210.4%+3,556.8%
YOY-302.8%-279.3%-23.5%
5Y-2,234.2%-436.8%-1,797.4%
10Y-1,305.5%-599.3%-706.2%
1.1.2. Return on Assets

Shows how efficient Capricor is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • -1.3% Return on Assets means that Capricor generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Capricor Therapeutics Inc:

  • The MRQ is -1.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 181.1%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ-1.3%TTM181.1%-182.4%
TTM181.1%YOY-12.8%+193.8%
TTM181.1%5Y24.4%+156.7%
5Y24.4%10Y4.2%+20.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.3%-13.6%+12.3%
TTM181.1%-12.9%+194.0%
YOY-12.8%-11.9%-0.9%
5Y24.4%-14.2%+38.6%
10Y4.2%-16.2%+20.4%
1.1.3. Return on Equity

Shows how efficient Capricor is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • -3.4% Return on Equity means Capricor generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Capricor Therapeutics Inc:

  • The MRQ is -3.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 1,577.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ-3.4%TTM1,577.9%-1,581.3%
TTM1,577.9%YOY-43.9%+1,621.8%
TTM1,577.9%5Y289.8%+1,288.1%
5Y289.8%10Y-135.6%+425.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.4%-17.0%+13.6%
TTM1,577.9%-16.1%+1,594.0%
YOY-43.9%-15.4%-28.5%
5Y289.8%-20.0%+309.8%
10Y-135.6%-21.1%-114.5%

1.2. Operating Efficiency of Capricor Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Capricor is operating .

  • Measures how much profit Capricor makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • An Operating Margin of -8.8% means the company generated $-0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Capricor Therapeutics Inc:

  • The MRQ is -8.8%. The company is operating very inefficient. -2
  • The TTM is -149.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8.8%TTM-149.0%+140.2%
TTM-149.0%YOY-312.4%+163.4%
TTM-149.0%5Y-2,989.6%+2,840.6%
5Y-2,989.6%10Y-1,758.8%-1,230.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.8%-286.1%+277.3%
TTM-149.0%-224.4%+75.4%
YOY-312.4%-288.4%-24.0%
5Y-2,989.6%-475.2%-2,514.4%
10Y-1,758.8%-624.7%-1,134.1%
1.2.2. Operating Ratio

Measures how efficient Capricor is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.09 means that the operating costs are $1.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 1.088. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.147. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.088TTM3.147-2.059
TTM3.147YOY3.698-0.551
TTM3.1475Y31.518-28.371
5Y31.51810Y21.596+9.921
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0882.997-1.909
TTM3.1473.247-0.100
YOY3.6983.766-0.068
5Y31.5185.675+25.843
10Y21.5967.857+13.739

1.3. Liquidity of Capricor Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Capricor is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.63 means the company has $1.63 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 1.626. The company is able to pay all its short-term debts. +1
  • The TTM is 1.221. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.626TTM1.221+0.405
TTM1.221YOY2.681-1.459
TTM1.2215Y7.272-6.051
5Y7.27210Y5.574+1.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6263.930-2.304
TTM1.2214.251-3.030
YOY2.6815.436-2.755
5Y7.2726.045+1.227
10Y5.5746.363-0.789
1.3.2. Quick Ratio

Measures if Capricor is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • A Quick Ratio of 2.39 means the company can pay off $2.39 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 2.387. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.709. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.387TTM1.709+0.678
TTM1.709YOY3.839-2.130
TTM1.7095Y8.167-6.458
5Y8.16710Y6.749+1.418
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3873.629-1.242
TTM1.7094.065-2.356
YOY3.8395.397-1.558
5Y8.1675.993+2.174
10Y6.7496.277+0.472

1.4. Solvency of Capricor Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Capricor assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Capricor to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.62 means that Capricor assets are financed with 61.5% credit (debt) and the remaining percentage (100% - 61.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 0.615. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.872. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.615TTM0.872-0.257
TTM0.872YOY0.694+0.178
TTM0.8725Y0.499+0.373
5Y0.49910Y0.732-0.233
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6150.332+0.283
TTM0.8720.334+0.538
YOY0.6940.268+0.426
5Y0.4990.366+0.133
10Y0.7320.390+0.342
1.4.2. Debt to Equity Ratio

Measures if Capricor is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Capricor to the Biotechnology industry mean.
  • A Debt to Equity ratio of 159.9% means that company has $1.60 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Capricor Therapeutics Inc:

  • The MRQ is 1.599. The company is just able to pay all its debts with equity.
  • The TTM is 6.281. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ1.599TTM6.281-4.682
TTM6.281YOY2.370+3.911
TTM6.2815Y2.090+4.191
5Y2.09010Y13.958-11.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5990.381+1.218
TTM6.2810.390+5.891
YOY2.3700.334+2.036
5Y2.0900.434+1.656
10Y13.9580.466+13.492

2. Market Valuation of Capricor Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Capricor generates.

  • Above 15 is considered overpriced but always compare Capricor to the Biotechnology industry mean.
  • A PE ratio of -50.54 means the investor is paying $-50.54 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Capricor Therapeutics Inc:

  • The EOD is -57.356. Based on the earnings, the company is expensive. -2
  • The MRQ is -50.535. Based on the earnings, the company is expensive. -2
  • The TTM is -16.035. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-57.356MRQ-50.535-6.821
MRQ-50.535TTM-16.035-34.501
TTM-16.035YOY-4.669-11.366
TTM-16.0355Y-9.073-6.962
5Y-9.07310Y-9.771+0.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-57.356-2.315-55.041
MRQ-50.535-2.560-47.975
TTM-16.035-2.664-13.371
YOY-4.669-4.122-0.547
5Y-9.073-6.258-2.815
10Y-9.771-6.108-3.663
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Capricor Therapeutics Inc:

  • The EOD is -3.547. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.125. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.259. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.547MRQ-3.125-0.422
MRQ-3.125TTM-0.259-2.866
TTM-0.259YOY-3.376+3.117
TTM-0.2595Y-6.589+6.330
5Y-6.58910Y-6.957+0.368
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.547-3.067-0.480
MRQ-3.125-3.251+0.126
TTM-0.259-3.545+3.286
YOY-3.376-5.595+2.219
5Y-6.589-8.315+1.726
10Y-6.957-8.708+1.751
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Capricor is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.82 means the investor is paying $6.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Capricor Therapeutics Inc:

  • The EOD is 7.736. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.816. Based on the equity, the company is overpriced. -1
  • The TTM is 5.776. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.736MRQ6.816+0.920
MRQ6.816TTM5.776+1.040
TTM5.776YOY8.206-2.431
TTM5.7765Y8.786-3.010
5Y8.78610Y47.678-38.892
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.7361.905+5.831
MRQ6.8162.111+4.705
TTM5.7762.095+3.681
YOY8.2062.836+5.370
5Y8.7863.443+5.343
10Y47.6783.794+43.884
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Capricor Therapeutics Inc.

3.1. Institutions holding Capricor Therapeutics Inc

Institutions are holding 21.616% of the shares of Capricor Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc3.71150.00011165404130861.1356
2023-12-31Woodline Partners LP2.89670.04849095429095420
2023-12-31BlackRock Inc1.1455035967310990.3065
2023-12-31Geode Capital Management, LLC1.0070.00023161984757017.7085
2023-12-31Susquehanna International Group, LLP0.47490.00011491151984015.3471
2023-12-31Renaissance Technologies Corp0.4660.0011146321103700243.3073
2023-12-31Northern Trust Corp0.40520.00011272292226921.2167
2023-12-31Advisor Group Holdings, Inc.0.37120.0011165501105501842.5
2023-12-31State Street Corporation0.27140852243000.3533
2023-12-31Bank of New York Mellon Corp0.26990.0001847594120.4885
2023-12-31LPL Financial Corp0.24920.000278238-3000-3.6929
2023-12-31Qube Research & Technologies0.17520.00055500949380877.2428
2023-12-31Jump Financial, LLC0.16820.008552800528000
2023-12-31Morgan Stanley - Brokerage Accounts0.1519047688500011.7129
2023-12-31SIMPLEX TRADING, LLC0.13610.000142740595916.2013
2023-12-31JANE STREET GROUP, LLC0.12750.000140039400390
2023-12-31GSA Capital Partners LLP0.1050.013532970-10835-24.7346
2023-12-31Commonwealth Equity Services Inc0.09870.00033099000
2023-12-31Goldman Sachs Group Inc0.0971030480593124.1598
2023-12-31Citigroup Inc0.07580.000123798-37793-61.3612
Total 12.4040.07443894767+1335849+34.3%

3.2. Funds holding Capricor Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.76430.000287083500
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.13680.001535811926550.7469
2024-02-29Fidelity Extended Market Index0.5460.0019172002-833-0.482
2024-03-31BlackRock Extended Equity Market K0.22760.0033717072071240.6157
2023-09-30BlackRock Extended Mkt Composite0.18550.00145845300
2024-02-29Fidelity Total Market Index0.1850.00035828300
2024-03-28iShares Micro-Cap ETF0.15510.03614887513452.8298
2024-02-29Fidelity Series Total Market Index0.13090.00034122300
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.11650.0028367121542172.4297
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.09360.0029294851241772.7502
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08790.002327676721435.2556
2023-12-31Northern Trust Extended Eq Market Idx0.08790.002327676721435.2556
2024-02-29Spartan Total Market Index Pool E0.07110.00032241400
2023-12-31Northern Small Cap Core K0.07050.02352222000
2024-02-29Fidelity Nasdaq Composite Index0.06940.00062187100
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.0610.000219231-748004-97.4935
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.0610.00021923100
2024-02-29Vanguard Balanced Index Inv0.05080.00011600000
2024-02-29Schwab Total Stock Market Index0.04280.00031347900
2024-02-29Spartan Extended Market Index Pool E0.03970.0021124968337.1422
Total 6.18340.08261947988-681026-35.0%

3.3. Insider Transactions

Insiders are holding 8.197% of the shares of Capricor Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-10-12David B MusketBUY4102.75
2023-10-09David B MusketBUY50832.82
2023-10-06Paul Gisbert AuwaerterBUY50002.84
2023-10-04David B MusketBUY25002.9

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Capricor Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7740.086+802%-0.155+120%0.029+2612%0.018+4117%
Book Value Per Share--0.7170.236+204%0.560+28%0.563+27%0.291+147%
Current Ratio--1.6261.221+33%2.681-39%7.272-78%5.574-71%
Debt To Asset Ratio--0.6150.872-29%0.694-11%0.499+23%0.732-16%
Debt To Equity Ratio--1.5996.281-75%2.370-33%2.090-24%13.958-89%
Dividend Per Share----0%-0%-0%-0%
Eps---0.024-0.177+631%-0.230+852%-0.147+508%-0.114+370%
Free Cash Flow Per Share---0.391-0.219-44%0.012-3266%-0.097-75%-0.143-63%
Free Cash Flow To Equity Per Share--0.344-0.016+105%0.051+574%0.051+581%17.168-98%
Gross Profit Margin--1.1121.028+8%1.000+11%1.006+11%1.003+11%
Intrinsic Value_10Y_max---0.342--------
Intrinsic Value_10Y_min---16.412--------
Intrinsic Value_1Y_max---0.405--------
Intrinsic Value_1Y_min---0.759--------
Intrinsic Value_3Y_max---0.933--------
Intrinsic Value_3Y_min---3.060--------
Intrinsic Value_5Y_max---1.122--------
Intrinsic Value_5Y_min---6.200--------
Market Cap174841650.000+12%154049670.000136329232.500+13%132155085.000+17%116712786.945+32%110860947.180+39%
Net Profit Margin---0.06333.464-100%-3.028+4703%-22.342+35338%-13.055+20608%
Operating Margin---0.088-1.490+1594%-3.124+3452%-29.896+33896%-17.588+19900%
Operating Ratio--1.0883.147-65%3.698-71%31.518-97%21.596-95%
Pb Ratio7.736+12%6.8165.776+18%8.206-17%8.786-22%47.678-86%
Pe Ratio-57.356-13%-50.535-16.035-68%-4.669-91%-9.073-82%-9.771-81%
Price Per Share5.550+12%4.8904.328+13%4.195+17%3.705+32%3.519+39%
Price To Free Cash Flow Ratio-3.547-13%-3.125-0.259-92%-3.376+8%-6.589+111%-6.957+123%
Price To Total Gains Ratio7.169+12%6.316-21.171+435%-31.324+596%-18.524+393%-66.187+1148%
Quick Ratio--2.3871.709+40%3.839-38%8.167-71%6.749-65%
Return On Assets---0.0131.811-101%-0.128+885%0.244-105%0.042-131%
Return On Equity---0.03415.779-100%-0.439+1201%2.898-101%-1.356+3922%
Total Gains Per Share--0.7740.086+802%-0.155+120%0.029+2612%0.018+4117%
Usd Book Value--22601467.0007437805.750+204%17646061.750+28%17728425.850+27%9166581.300+147%
Usd Book Value Change Per Share--0.7740.086+802%-0.155+120%0.029+2612%0.018+4117%
Usd Book Value Per Share--0.7170.236+204%0.560+28%0.563+27%0.291+147%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.024-0.177+631%-0.230+852%-0.147+508%-0.114+370%
Usd Free Cash Flow---12323274.000-6911019.500-44%389226.500-3266%-3070461.800-75%-4501607.425-63%
Usd Free Cash Flow Per Share---0.391-0.219-44%0.012-3266%-0.097-75%-0.143-63%
Usd Free Cash Flow To Equity Per Share--0.344-0.016+105%0.051+574%0.051+581%17.168-98%
Usd Market Cap174841650.000+12%154049670.000136329232.500+13%132155085.000+17%116712786.945+32%110860947.180+39%
Usd Price Per Share5.550+12%4.8904.328+13%4.195+17%3.705+32%3.519+39%
Usd Profit---762089.00098538614.500-101%-7198267.788+845%16202001.093-105%6834991.346-111%
Usd Revenue--12088089.0006294516.500+92%637229.250+1797%13697013.050-12%7272361.675+66%
Usd Total Gains Per Share--0.7740.086+802%-0.155+120%0.029+2612%0.018+4117%
 EOD+6 -2MRQTTM+25 -9YOY+27 -75Y+22 -1210Y+23 -11

4.2. Fundamental Score

Let's check the fundamental score of Capricor Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-57.356
Price to Book Ratio (EOD)Between0-17.736
Net Profit Margin (MRQ)Greater than0-0.063
Operating Margin (MRQ)Greater than0-0.088
Quick Ratio (MRQ)Greater than12.387
Current Ratio (MRQ)Greater than11.626
Debt to Asset Ratio (MRQ)Less than10.615
Debt to Equity Ratio (MRQ)Less than11.599
Return on Equity (MRQ)Greater than0.15-0.034
Return on Assets (MRQ)Greater than0.05-0.013
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Capricor Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.275
Ma 20Greater thanMa 506.506
Ma 50Greater thanMa 1005.427
Ma 100Greater thanMa 2004.779
OpenGreater thanClose5.980
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets58,734
Total Liabilities36,133
Total Stockholder Equity22,601
 As reported
Total Liabilities 36,133
Total Stockholder Equity+ 22,601
Total Assets = 58,734

Assets

Total Assets58,734
Total Current Assets50,855
Long-term Assets7,879
Total Current Assets
Cash And Cash Equivalents 14,695
Short-term Investments 24,793
Net Receivables 10,372
Other Current Assets 996
Total Current Assets  (as reported)50,855
Total Current Assets  (calculated)50,855
+/-0
Long-term Assets
Property Plant Equipment 7,611
Long-term Assets Other 268
Long-term Assets  (as reported)7,879
Long-term Assets  (calculated)7,879
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities31,270
Long-term Liabilities4,863
Total Stockholder Equity22,601
Total Current Liabilities
Short-term Debt 749
Accounts payable 6,250
Total Current Liabilities  (as reported)31,270
Total Current Liabilities  (calculated)6,999
+/- 24,270
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,487
Long-term Liabilities Other 3,376
Long-term Liabilities  (as reported)4,863
Long-term Liabilities  (calculated)4,863
+/-0
Total Stockholder Equity
Common Stock31
Retained Earnings -159,367
Accumulated Other Comprehensive Income 236
Other Stockholders Equity 181,702
Total Stockholder Equity (as reported)22,601
Total Stockholder Equity (calculated)22,601
+/-0
Other
Capital Stock31
Cash and Short Term Investments 39,488
Common Stock Shares Outstanding 30,664
Current Deferred Revenue24,270
Liabilities and Stockholders Equity 58,734
Net Debt -9,083
Net Invested Capital 22,601
Net Working Capital 19,586
Property Plant and Equipment Gross 9,817
Short Long Term Debt Total 5,612



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
1
9
4
1
1
3
0
3
0
0
1
0
4
0
0
18,623
17,089
14,487
11,190
8,409
6,435
4,263
2,254
4,829
3,620
2,372
5,872
4,809
3,666
2,418
3,704
3,091
1,372
1,372
1,000
495
227
495
295
114
5,538
15,977
18,437
16,283
13,632
27,471
23,691
19,882
16,070
16,985
13,892
24,472
18,747
14,068
14,218
15,794
16,274
15,388
14,327
12,233
9,247
8,618
7,307
7,907
11,114
14,294
37,126
36,187
34,619
43,544
39,930
43,101
41,330
64,922
58,066
53,928
50,095
53,863
46,011
37,152
58,734
58,73437,15246,01153,86350,09553,92858,06664,92241,33043,10139,93043,54434,61936,18737,12614,29411,1147,9077,3078,6189,24712,23314,32715,38816,27415,79414,21814,06818,74724,47213,89216,98516,07019,88223,69127,47113,63216,28318,43715,9775,5381142954952274951,0001,3721,3723,0913,7042,4183,6664,8095,8722,3723,6204,8292,2544,2636,4358,40911,19014,48717,08918,62300401003031149100000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
1
9
4
1
1
3
0
3
0
0
1
0
4
0
0
18,408
16,760
14,044
10,764
8,005
6,046
3,946
1,956
4,556
3,433
2,296
5,801
4,740
3,597
2,352
3,640
3,028
1,310
1,310
942
438
172
438
289
109
3,681
14,031
16,410
14,196
11,608
25,420
21,643
17,714
13,990
14,890
11,809
22,404
18,108
13,465
13,640
15,232
14,125
13,165
13,541
11,393
8,471
7,904
6,643
6,828
9,885
13,770
36,253
35,491
33,677
41,880
38,731
41,298
36,437
59,634
52,624
47,505
42,889
46,595
38,924,873
29,527
50,855
50,85529,52738,924,87346,59542,88947,50552,62459,63436,43741,29838,73141,88033,67735,49136,25313,7709,8856,8286,6437,9048,47111,39313,54113,16514,12515,23213,64013,46518,10822,40411,80914,89013,99017,71421,64325,42011,60814,19616,41014,0313,6811092894381724389421,3101,3103,0283,6402,3523,5974,7405,8012,2963,4334,5561,9563,9466,0468,00510,76414,04416,76018,40800401003031149100000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
1
9
4
1
1
3
0
3
0
0
1
0
4
0
0
18,039
16,233
13,660
10,348
7,364
5,501
3,607
1,770
4,224
3,176
2,013
5,563
4,436
3,378
2,124
3,260
2,607
1,039
1,039
777
283
47
283
229
71
1,730
12,979
11,582
9,805
8,035
6,939
20,533
17,218
5,568
11,766
8,851
20,521
16,195
2,750
12,259
13,895
14,125
13,165
12,334
4,378
4,259
7,170
5,891
6,828
3,899
13,217
36,253
35,300
32,666
41,880
38,078
40,839
34,885
58,334
16,394
8,414
9,603
10,606
9,837,133
8,985
14,695
14,6958,9859,837,13310,6069,6038,41416,39458,33434,88540,83938,07841,88032,66635,30036,25313,2173,8996,8285,8917,1704,2594,37812,33413,16514,12513,89512,2592,75016,19520,5218,85111,7665,56817,21820,5336,9398,0359,80511,58212,9791,73071229283472837771,0391,0392,6073,2602,1243,3784,4365,5632,0133,1764,2241,7703,6075,5017,36410,34813,66016,23318,03900401003031149100000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326
326
326
325
2,977
15,484
15,494
12,999
7,999
2,498
2,500
2,500
12,991
8,993
3,999
4,998
7,985
5,995
5,995
5,994
2,997
2,997
0
0
5,986
5,986
0
0
0
0
0
0
0
0
35,023
38,200
31,818
34,566
27,956,325
19,537
24,793
24,79319,53727,956,32534,56631,81838,20035,023000000005,9865,986002,9972,9975,9945,9955,9957,9854,9983,9998,99312,9912,5002,5002,4987,99912,99915,49415,4842,977325326326326000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
261
360
746
380
403
212
304
218
1,163
223
197
313
537
345
307
287
173
205
123
144
101
88
119
50
17
56
0
0
180
392
357
548
548
548
548
547,580
548
10,372
10,372548547,58054854854854835739218000561750119881011441232051732873073455373131972231,163218304212403380746360261010000000000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
369
526
385
416
641
545
339
185
332
258
283
237
304
219
228
380
421
271
271
165
156
125
156
60
38
223
170
123
105
236
203
131
92
211
321
239
118
343
398
239
190
501
522
388
426
724
611
608
129
571
434
250
174
1,011
736
653
279
1,160
943
659
344
920
875
583,835
458
996
996458583,8358759203446599431,1602796537361,01117425043457112960861172442638852250119023939834311823932121192131203236105123170223386015612515616527127142138022821930423728325833218533954564141638552636900000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215
330
443
426
404
390
317
298
273
186
75
72
69
69
67
65
63
62
62
58
57
55
57
6
5
1,857
1,946
2,028
2,087
2,025
2,051
2,048
2,169
2,080
2,095
2,083
2,067
639
603
578
561
2,149
2,224
786
840
776
713
664
1,080
1,228
524
873
696
942
1,665
1,199
1,802
4,893
5,288
5,442
6,423
7,206
7,269
7,086,325
7,625
7,879
7,8797,6257,086,3257,2697,2066,4235,4425,2884,8931,8021,1991,6659426968735241,2281,0806647137768407862,2242,1495615786036392,0672,0832,0952,0802,1692,0482,0512,0252,0872,0281,9461,857565755575862626365676969727518627329831739040442644333021500000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58
63
88
86
80
74
66
60
32
27
23
20
17
17
15
13
11
10
10
6
5
3
5
1
1
74
164
204
225
229
254
263
332
319
345
355
352
435
412
399
394
372
535
507
622
574
542
507
475
443
411
487
604
851
839
1,110
1,514
4,618
5,012
5,174
6,155
6,938
7,001
6,818,153
7,357
7,611
7,6117,3576,818,1537,0016,9386,1555,1745,0124,6181,5141,110839851604487411443475507542574622507535372394399412435352355345319332263254229225204164741153561010111315171720232732606674808688635800000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000002000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127
253
236
234
218
210
144
131
133
107
107
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,757
1,756
1,769
1,807
1,740
1,728
1,715
1,703
1,691
1,679
1,667
1,654
142
130
118
106
93
82
71,410
61
50
39
28
17,314
6,495
5,413
4,330
3
2
1,083
0
0
0
0
0
0
0
0
0
0
0
000000000001,083234,3305,4136,49517,3142839506171,41082931061181301421,6541,6671,6791,6911,7031,7151,7281,7401,8071,7691,7561,7570000000000000010710713313114421021823423625312700000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52
52
0
52
0
0
0
0
0
0
1,783
1,782
1,824
1,862
1,795
1,797
1,785
1,836
1,761
1,750
1,728
1,716
204
191
179
168
189
158
207
157
152
133
129
125
120
107
82
89
89
89
89
289
276
276
58,066
0
268
0
-45,965,187
0
0
00-45,965,1870268058,06627627628989898989821071201251291331521572071581891681791912041,7161,7281,7501,7611,8361,7851,7971,7951,8621,8241,7821,783000000520525200000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
9
9
12
21
25
25
35
35
42
52
50
50
59
67
67
74
78
83
90
125
135
145
168
1,357
1,889
1,379
1,000
918
1,332
778
440
845
638
889
1,150
1,505
1,069
744
436
718
541
541
458
468
394
468
1,528
1,682
6,073
17,636
21,522
20,755
19,881
20,147
19,136
17,957
17,101
18,068
19,008
24,423
22,751
21,260
20,805
20,064
5,047
4,854
4,696
5,252
4,631
4,877
4,943
4,337
4,274
4,701
5,472
5,779
6,419
7,164
6,550
6,365
9,962
40,279
39,337
38,502
38,309
47,657
43,280
38,940
36,133
36,13338,94043,28047,65738,30938,50239,33740,2799,9626,3656,5507,1646,4195,7795,4724,7014,2744,3374,9434,8774,6315,2524,6964,8545,04720,06420,80521,26022,75124,42319,00818,06817,10117,95719,13620,14719,88120,75521,52217,6366,0731,6821,5284683944684585415417184367441,0691,5051,1508896388454407781,3329181,0001,3791,8891,357168145135125908378746767595050524235352525211299000
   > Total Current Liabilities 
0
0
0
9
9
12
21
25
25
35
35
42
52
50
50
59
67
67
74
78
83
90
125
135
145
168
1,357
1,889
1,311
1,000
918
1,332
778
440
845
638
889
1,150
1,505
1,069
744
436
718
541
541
267
287
331
287
1,016
1,182
2,053
6,299
6,492
6,192
6,300
7,545
6,863
6,534
6,529
7,341
6,205
6,670
4,895
3,299
16,644
16,688
1,671
1,478
1,320
1,876
1,255
1,501
1,567
961
898
1,325
1,918
2,278
2,971
3,752
3,174
2,988
4,133
14,323
19,547
23,195
23,587
37,132
35,153,674
32,927
31,270
31,27032,92735,153,67437,13223,58723,19519,54714,3234,1332,9883,1743,7522,9712,2781,9181,3258989611,5671,5011,2551,8761,3201,4781,67116,68816,6443,2994,8956,6706,2057,3416,5296,5346,8637,5456,3006,1926,4926,2992,0531,1821,0162873312872675415417184367441,0691,5051,1508896388454407781,3329181,0001,3111,8891,357168145135125908378746767595050524235352525211299000
       Short-term Debt 
0
0
0
0
0
2
6
8
8
29
32
37
47
47
48
52
62
63
69
69
75
77
125
125
132
166
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
191
259
327
0
0
0
0
9,156
0
-2,734
-1,823
9,156
0
0
699
13,906
13,906
14,156
14,156
0
0
0
0
0
0
0
0
0
0
140
193
247
283
0
0
418
498
580
698
682
694
707,425
730
749
749730707,42569468269858049841800283247193140000000000014,15614,15613,90613,906699009,156-1,823-2,73409,1560000327259191000000000000000000000016613212512577756969636252484747373229886200000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,156
0
0
0
9,156
0
0
0
13,906
13,906
14,156
14,156
0
0
0
0
0
0
0
0
0
0
140
193
247
283
0
0
0
0
0
0
0
0
0
0
0
00000000000283247193140000000000014,15614,15613,90613,9060009,1560009,1560000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
8
9
8
9
9
5
3
5
5
3
3
7
5
4
5
8
8
13
0
9
11
0
573
659
816
696
559
746
456
281
306
235
165
154
592
332
479
238
504
541
438
122
287
331
210
398
339
1,507
1,519
1,683
1,914
1,699
2,746
2,679
2,309
2,531
3,224
2,924
3,920
3,039
2,506
2,177
1,264
1,496
1,478
1,320
1,876
1,255
1,501
1,567
961
898
1,325
1,778
2,085
2,725
3,469
2,782
2,459
3,116
3,524
3,128
3,937
4,835
5,426
5,134
-6,785,158
6,250
6,250-6,785,1585,1345,4264,8353,9373,1283,5243,1162,4592,7823,4692,7252,0851,7781,3258989611,5671,5011,2551,8761,3201,4781,4961,2642,1772,5063,0393,9202,9243,2242,5312,3092,6792,7461,6991,9141,6831,5191,5073393982103312871224385415042384793325921541652353062814567465596968166595730119013885457335535998980000
       Other Current Liabilities 
0
0
0
0
1
1
7
7
7
1
1
0
0
0
0
0
0
0
0
0
0
0
124,968
1
2
2
784
1,231
495
304
360
586
322
160
539
403
725
996
913
737
265
199
213
0
104
145
0
0
77
359
516
546
614
642
112
434
633
539
580
352
471
547
3,920
489
110
311
1,268
174
0
0
0
0
1,501
1,567
0
0
1,325
1,778
2,277,960
2,971,282
3,469
3,174
2,988
3,716
4,098
94
3,937
89
5,426
5,128,676
6,791,950
0
06,791,9505,128,6765,426893,937944,0983,7162,9883,1743,4692,971,2822,277,9601,7781,325001,5671,50100001741,2683111104893,920547471352580539633434112642614546516359770014510402131992657379139967254035391603225863603044951,231784221124,9680000000000011777110000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
191
181
63
181
512
500
4,020
11,337
15,030
14,562
13,581
12,601
12,272
11,422
10,573
10,727
12,804
17,752
17,855
17,961
4,160
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,554
3,501
3,448
3,412
3,376
3,376
5,829
25,956
19,789
15,307
14,722
10,525
8,126,361
6,013
4,863
4,8636,0138,126,36110,52514,72215,30719,78925,9565,8293,3763,3763,4123,4483,5013,5543,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3764,16017,96117,85517,75212,80410,72710,57311,42212,27212,60113,58114,56215,03011,3374,020500512181631811910000000000000000680000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,642
9,156
9,156
9,156
9,156
9,156
9,156
10,156
12,156
17,006
17,006
17,006
0
0
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,554
3,501
3,448
3,412
3,376
0
3,376
0
3,376
3,376
3,376
3,376
3,376
0
0
003,3763,3763,3763,3763,37603,37603,3763,4123,4483,5013,5543,3763,3763,3763,3763,3763,3763,3763,3763,3763,3760017,00617,00617,00612,15610,1569,1569,1569,1569,1569,1569,1568,64200000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58
7,375
6,388
5,407
4,426
3,444
3,116
2,267
1,417
571
647
3,847
3,949
4,055
4,160
3,377
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
3,376
23,650
17,631
0
12,844
0
6,608
0
0
006,608012,844017,63123,6503,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3774,1604,0553,9493,8476475711,4172,2673,1163,4444,4265,4076,3887,37558000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,250
5,208
4,167
3,125
2,734
1,823
911
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000009111,8232,7343,1254,1675,2086,25000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
-9
-12
-21
-25
-25
-35
-35
-41
-43
-46
-49
-59
-64
-67
-71
-78
-83
-90
-125
-135
-145
-168
17,266
15,200
13,108
10,190
7,491
5,104
3,484
1,814
3,984
2,982
1,483
4,723
3,304
2,597
1,674
3,268
2,373
831
831
542
27
-167
27
-1,233
-1,568
-535
-1,659
-3,085
-4,472
-6,249
7,325
4,555
1,926
-1,032
-1,083
-5,116
49
-4,003
-7,192
-6,586
-4,271
11,227
10,534
9,631
6,980
4,616
3,740
2,364
3,570
6,839
9,593
31,654
30,408
28,200
36,381
33,380
36,736
31,368
24,643
18,729
15,426
11,786
6,206
2,731
-1,788
22,601
22,601-1,7882,7316,20611,78615,42618,72924,64331,36836,73633,38036,38128,20030,40831,6549,5936,8393,5702,3643,7404,6166,9809,63110,53411,227-4,271-6,586-7,192-4,00349-5,116-1,083-1,0321,9264,5557,325-6,249-4,472-3,085-1,659-535-1,568-1,23327-167275428318312,3733,2681,6742,5973,3044,7231,4832,9823,9841,8143,4845,1047,49110,19013,10815,20017,266-168-145-135-125-90-83-78-71-67-64-59-49-46-43-41-35-35-25-25-21-12-90000
   Common Stock
0
0
0
0
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
1
1
24
24
24
24
24
24
24
24
27
27
27
35
35
35
35
40
40
40
40
43
43
43
43
43
44
12
12
12
12
12
16
16
16
16
18
18
21
21
21
23
25
26
28
30
31
31
34
3
4
5
9
20
20
21
23
23
24
24
24
24
25
25
25
25,764
26
31
312625,7642525252424242423232120209543343131302826252321212118181616161612121212124443434343434040404035353535272727242424242424242411888888888888888888880000
   Retained Earnings Total Equity00-152,215-144,848-137,080-129,359-122,9880-108,0600-97,938-93,190-88,038-83,860-79,950-76,466-74,381-72,911-71,305-69,258-66,739-63,479-59,343-55,219-51,548-63,853-61,118-57,646-53,979-49,461-44,128-39,439-35,172-31,826-28,914-25,791-22,315-20,387-18,843-17,309-16,099-48,137-47,788-47,191-46,708-46,506-45,940-45,587-44,815-43,151-42,00700000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8
-14
-14
-14
-14
-34
-34
0
0
-39
-39
0
0
-52
-52
0
0
-41
-41
0
0
-47
-47
-47
0
-1
0
-1
-2
-112
-4
7
12
9
3
5
1
4
10
7
9
12
20
18
20
12
-489
-518
-550
-1
-611
-642
-678
0
0
0
0
0
0
23
122
105
95
179,693
113
236
236113179,6939510512223000000-678-642-611-1-550-518-4891220182012971041539127-4-112-2-10-10-47-47-4700-41-4100-52-5200-39-3900-34-34-14-14-14-14-800000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,235
45,484
45,606
45,778
46,439
46,490
46,498
46,505
46,512
46,526
15,553
15,638
15,748
15,905
16,055
33,104
33,447
33,724
34,115
38,335
38,989
49,488
49,951
50,423
54,502
59,549
62,737
65,705
68,925
70,409
71,311
72,965
73,665
76,478
81,216
86,049
111,584
114,248
116,217
129,548
131,295
0
139,404
0
141,670
144,638
148,735
150,934
154,740
0
0
00154,740150,934148,735144,638141,6700139,4040131,295129,548116,217114,248111,58486,04981,21676,47873,66572,96571,31170,40968,92565,70562,73759,54954,50250,42349,95149,48838,98938,33534,11533,72433,44733,10416,05515,90515,74815,63815,55346,52646,51246,50546,49846,49046,43945,77845,60645,48445,23500000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
43
45
47
47
47
54
54
27,628
28,085
29,052
29,911
30,532
31,140
31,265
32,095
36,290
36,893
37,286
42,013
42,404
42,545
42,766
45,235
45,484
0
45,647
46,439
0
0
46,490
46,512
46,526
15,553
15,638
15,748
15,905
16,055
33,104
33,447
33,724
34,115
38,335
38,989
49,488
49,951
50,423
54,502
59,549
62,737
65,705
68,925
70,409
71,311
72,965
73,665
76,478
81,216
86,049
111,584
114,248
116,217
129,548
131,295
138,582
139,404
140,497
141,670
144,638
148,735
150,934
152,011,930
156,679
181,702
181,702156,679152,011,930150,934148,735144,638141,670140,497139,404138,582131,295129,548116,217114,248111,58486,04981,21676,47873,66572,96571,31170,40968,92565,70562,73759,54954,50250,42349,95149,48838,98938,33534,11533,72433,44733,10416,05515,90515,74815,63815,55346,52646,51246,4900046,43945,647045,48445,23542,76642,54542,40442,01337,28636,89336,29032,09531,26531,14030,53229,91129,05228,08527,628545447474745434343434343434343434343434343430000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue25,178
Cost of Revenue-1,069
Gross Profit24,10924,109
 
Operating Income (+$)
Gross Profit24,109
Operating Expense-48,187
Operating Income-24,078-24,078
 
Operating Expense (+$)
Research Development35,822
Selling General Administrative12,366
Selling And Marketing Expenses-12,795,296
Operating Expense48,187-12,747,109
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-24,078
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-22,288-25,868
EBIT - interestExpense = -24,078
-22,288
-22,288
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-24,078-22,288
Earnings Before Interest and Taxes (EBITDA)-23,009
 
After tax Income (+$)
Income Before Tax-22,288
Tax Provision-0
Net Income From Continuing Ops-29,246-22,288
Net Income-22,288
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses49,256
Total Other Income/Expenses Net1,7900
 

Technical Analysis of Capricor
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Capricor. The general trend of Capricor is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Capricor's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Capricor Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.8 < 7.22 < 7.28.

The bearish price targets are: 5.48 > 3.56 > 3.3899.

Tweet this
Capricor Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Capricor Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Capricor Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Capricor Therapeutics Inc. The current macd is 0.07331544.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Capricor price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Capricor. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Capricor price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Capricor Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartCapricor Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Capricor Therapeutics Inc. The current adx is 27.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Capricor shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Capricor Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Capricor Therapeutics Inc. The current sar is 7.10585889.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Capricor Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Capricor Therapeutics Inc. The current rsi is 38.28. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Capricor Therapeutics Inc Daily Relative Strength Index (RSI) ChartCapricor Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Capricor Therapeutics Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Capricor price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Capricor Therapeutics Inc Daily Stochastic Oscillator ChartCapricor Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Capricor Therapeutics Inc. The current cci is -177.35348588.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Capricor Therapeutics Inc Daily Commodity Channel Index (CCI) ChartCapricor Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Capricor Therapeutics Inc. The current cmo is -45.48643598.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Capricor Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartCapricor Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Capricor Therapeutics Inc. The current willr is -94.02173913.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Capricor Therapeutics Inc Daily Williams %R ChartCapricor Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Capricor Therapeutics Inc.

Capricor Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Capricor Therapeutics Inc. The current atr is 0.4558885.

Capricor Therapeutics Inc Daily Average True Range (ATR) ChartCapricor Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Capricor Therapeutics Inc. The current obv is 2,776,305.

Capricor Therapeutics Inc Daily On-Balance Volume (OBV) ChartCapricor Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Capricor Therapeutics Inc. The current mfi is 17.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Capricor Therapeutics Inc Daily Money Flow Index (MFI) ChartCapricor Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Capricor Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Capricor Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Capricor Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.275
Ma 20Greater thanMa 506.506
Ma 50Greater thanMa 1005.427
Ma 100Greater thanMa 2004.779
OpenGreater thanClose5.980
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Capricor with someone you think should read this too:
  • Are you bullish or bearish on Capricor? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Capricor? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Capricor Therapeutics Inc

I send you an email if I find something interesting about Capricor Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Capricor Therapeutics Inc.

Receive notifications about Capricor Therapeutics Inc in your mailbox!